NASDAQ : CARL

Carlsmed, Inc. — Company profile

Healthcare · Health Information Services · United States

Last price 15.0398 USD (Oct 30, 2026, 3:23 PM EDT) · Market cap 410.63M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Details

NameCarlsmed, Inc.
SectorHealthcare
IndustryHealth Information Services
Employees127
Founded2018
Ipo Date2025-07-23
CeoMichael Cordonnier
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
Ipo Price15.00
IsinUS14280C1053
Cusip14280C105
Cik1794546
Sic3841
Stock TypeCommon Stock

Key executives

NameTitle
Michael John CordonnierCo-Founder, Chairman, Chief Executive Officer and President
Niall Patrick Casey J.D.Co-Founder, Chief Intellectual Property Officer and Director
William DurallChief Commercial Officer
Richard J. HeppenstallChief Financial Officer
Jeff BertoliniChief Operating Officer
Shariq HussainChief Technology Officer
Stephanie ZhadkevichVice President and Head of Investor Relations
Jenifer KamocsayChief Legal Officer and Secretary
Jodi Allen Coe M.B.A.Senior Vice President of People and Culture
Sharon V. SchulzkiChief Clinical and Market Access Officer

Contact

Address1800 Aston Avenue, Suite 100, Carlsbad, California 92008, United States
Phone760 766 1923
Websitehttps://carlsmed.com